...
机译:用新型抗HER2结构域II / III抗体靶向EGFR / HER2杂二聚合
Shanghai Univ Med &
Hlth Sci Shanghai Key Lab Mol Imaging Shanghai 201318 Peoples R China;
Second Mil Med Univ Int Joint Canc Inst Shanghai 200433 Peoples R China;
Second Mil Med Univ Coll Basic Med Sci Dept Biophys 800 Xiangyin Rd Shanghai 200433 Peoples R;
Second Mil Med Univ Int Joint Canc Inst Shanghai 200433 Peoples R China;
Second Mil Med Univ Int Joint Canc Inst Shanghai 200433 Peoples R China;
Fudan Univ Shanghai Med Coll Dept Oncol Shanghai Canc Ctr Dept Med Oncol Shanghai 200032;
Shanghai Univ Med &
Hlth Sci Shanghai Key Lab Mol Imaging Shanghai 201318 Peoples R China;
Shanghai Univ Med &
Hlth Sci Shanghai Key Lab Mol Imaging Shanghai 201318 Peoples R China;
Shanghai Univ Med &
Hlth Sci Shanghai Key Lab Mol Imaging Shanghai 201318 Peoples R China;
Shanghai Univ Med &
Hlth Sci Shanghai Key Lab Mol Imaging Shanghai 201318 Peoples R China;
Second Mil Med Univ Int Joint Canc Inst Shanghai 200433 Peoples R China;
Second Mil Med Univ Coll Basic Med Sci Dept Biophys 800 Xiangyin Rd Shanghai 200433 Peoples R;
Second Mil Med Univ Coll Basic Med Sci Dept Biophys 800 Xiangyin Rd Shanghai 200433 Peoples R;
Shanghai Univ Med &
Hlth Sci Shanghai Key Lab Mol Imaging Shanghai 201318 Peoples R China;
Breast cancer; HER2; Transmembrane signal transduction; Structural analysis;
机译:用新型抗HER2结构域II / III抗体靶向EGFR / HER2杂二聚合
机译:用甲氨蝶呤包封的TETRA特异性非重叠可变域重链抗HER2抗体 - 脂质体与甲氨蝶呤过表达乳腺癌细胞的多价靶向和杀伤HER2过表达乳腺癌细胞:体外概念验证
机译:抗HER2单结构域抗体 - 缀合的树枝状大分子,用于靶向递送截断转基因乳腺癌细胞
机译:使用抗HER2治疗性抗体监测沿细胞内运输途径的受体异二聚体
机译:分析合成抗HER2抗体 - 药物缀合物的疗效和细胞毒性
机译:针对EGFR结构域III表位的新型单结构域抗体表现出抗肿瘤作用
机译:使用抗CD3 X抗HER2双特异性抗体武装活化T细胞(HER2蝙蝠)治疗患有第III期乳腺癌的妇女的内源性细胞因子反应和意外存活
机译:对接受曲妥珠单抗单一疗法的IIIB和IV期HER2阳性乳腺癌患者施用HER-2 / neu(HER2)细胞内结构域(ICD)基于肽的疫苗的II期研究;年度报告。 2007年4月27日至2008年4月26日